nodes	percent_of_prediction	percent_of_DWPC	metapath
Fulvestrant—ESR2—obesity	0.313	0.619	CbGaD
Fulvestrant—ESR1—obesity	0.193	0.381	CbGaD
Fulvestrant—CYP3A4—Sibutramine—obesity	0.032	0.27	CbGbCtD
Fulvestrant—CYP3A4—Benzphetamine—obesity	0.0243	0.204	CbGbCtD
Fulvestrant—CYP3A4—Bupropion—obesity	0.0206	0.174	CbGbCtD
Fulvestrant—CYP3A4—Orlistat—obesity	0.0168	0.142	CbGbCtD
Fulvestrant—NR1H4—bile—obesity	0.0152	0.188	CbGeAlD
Fulvestrant—CYP3A4—Cimetidine—obesity	0.0151	0.128	CbGbCtD
Fulvestrant—CYP3A4—Topiramate—obesity	0.00991	0.0835	CbGbCtD
Fulvestrant—ESR2—ovarian follicle—obesity	0.00911	0.112	CbGeAlD
Fulvestrant—ESR1—ovarian follicle—obesity	0.00624	0.077	CbGeAlD
Fulvestrant—NR1H4—gall bladder—obesity	0.00423	0.0522	CbGeAlD
Fulvestrant—NR1H4—adrenal cortex—obesity	0.0022	0.0271	CbGeAlD
Fulvestrant—ESRRA—islet of Langerhans—obesity	0.00212	0.0262	CbGeAlD
Fulvestrant—Estradiol—FABP2—obesity	0.00203	0.435	CrCbGaD
Fulvestrant—NR1H4—cardiovascular system—obesity	0.002	0.0247	CbGeAlD
Fulvestrant—ESRRA—respiratory system—obesity	0.002	0.0247	CbGeAlD
Fulvestrant—ESR2—hindbrain—obesity	0.00197	0.0243	CbGeAlD
Fulvestrant—EPHX2—adrenal cortex—obesity	0.00192	0.0237	CbGeAlD
Fulvestrant—ESRRA—adrenal cortex—obesity	0.00168	0.0208	CbGeAlD
Fulvestrant—NR1H4—digestive system—obesity	0.00166	0.0205	CbGeAlD
Fulvestrant—NR1H4—adrenal gland—obesity	0.00159	0.0196	CbGeAlD
Fulvestrant—EPHX2—pituitary gland—obesity	0.00155	0.0191	CbGeAlD
Fulvestrant—EPHX2—adipose tissue—obesity	0.00155	0.0191	CbGeAlD
Fulvestrant—ESRRA—cardiovascular system—obesity	0.00153	0.0189	CbGeAlD
Fulvestrant—EPHX2—adrenal gland—obesity	0.00139	0.0171	CbGeAlD
Fulvestrant—NR1H4—endocrine gland—obesity	0.00137	0.017	CbGeAlD
Fulvestrant—ESRRA—pituitary gland—obesity	0.00136	0.0168	CbGeAlD
Fulvestrant—ESRRA—adipose tissue—obesity	0.00135	0.0167	CbGeAlD
Fulvestrant—ESR1—hindbrain—obesity	0.00135	0.0166	CbGeAlD
Fulvestrant—ESRRA—digestive system—obesity	0.00127	0.0157	CbGeAlD
Fulvestrant—NR1H4—liver—obesity	0.00124	0.0153	CbGeAlD
Fulvestrant—ESRRA—adrenal gland—obesity	0.00121	0.015	CbGeAlD
Fulvestrant—ESR2—respiratory system—obesity	0.0012	0.0148	CbGeAlD
Fulvestrant—EPHX2—liver—obesity	0.00108	0.0134	CbGeAlD
Fulvestrant—ESRRA—endocrine gland—obesity	0.00105	0.013	CbGeAlD
Fulvestrant—ESRRA—liver—obesity	0.000949	0.0117	CbGeAlD
Fulvestrant—ESR2—cardiovascular system—obesity	0.000921	0.0114	CbGeAlD
Fulvestrant—ESR1—respiratory system—obesity	0.000824	0.0102	CbGeAlD
Fulvestrant—ESR2—pituitary gland—obesity	0.000816	0.0101	CbGeAlD
Fulvestrant—ESR2—digestive system—obesity	0.000765	0.00944	CbGeAlD
Fulvestrant—ESR2—adrenal gland—obesity	0.000729	0.00899	CbGeAlD
Fulvestrant—Estradiol—NR1I2—obesity	0.000688	0.147	CrCbGaD
Fulvestrant—ESR2—endocrine gland—obesity	0.000632	0.0078	CbGeAlD
Fulvestrant—ESR1—cardiovascular system—obesity	0.000631	0.00779	CbGeAlD
Fulvestrant—ESR2—liver—obesity	0.00057	0.00703	CbGeAlD
Fulvestrant—ESR1—pituitary gland—obesity	0.000559	0.00689	CbGeAlD
Fulvestrant—ESR1—adipose tissue—obesity	0.000556	0.00687	CbGeAlD
Fulvestrant—ESR1—digestive system—obesity	0.000524	0.00646	CbGeAlD
Fulvestrant—ESR1—adrenal gland—obesity	0.000499	0.00616	CbGeAlD
Fulvestrant—Influenza—Sibutramine—obesity	0.000439	0.00325	CcSEcCtD
Fulvestrant—Dyspnoea—Diethylpropion—obesity	0.000438	0.00324	CcSEcCtD
Fulvestrant—Hypersensitivity—Phenylpropanolamine—obesity	0.000435	0.00321	CcSEcCtD
Fulvestrant—Estradiol—ESR2—obesity	0.000434	0.0927	CrCbGaD
Fulvestrant—ESR1—endocrine gland—obesity	0.000433	0.00534	CbGeAlD
Fulvestrant—Headache—Phendimetrazine—obesity	0.000433	0.0032	CcSEcCtD
Fulvestrant—Dyspepsia—Diethylpropion—obesity	0.000432	0.0032	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Cimetidine—obesity	0.000426	0.00315	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Diethylpropion—obesity	0.000424	0.00313	CcSEcCtD
Fulvestrant—Constipation—Diethylpropion—obesity	0.00042	0.0031	CcSEcCtD
Fulvestrant—Hepatic enzyme increased—Topiramate—obesity	0.000411	0.00304	CcSEcCtD
Fulvestrant—Nausea—Phendimetrazine—obesity	0.00041	0.00303	CcSEcCtD
Fulvestrant—Bone pain—Topiramate—obesity	0.000406	0.003	CcSEcCtD
Fulvestrant—Asthenia—Phentermine—obesity	0.000405	0.00299	CcSEcCtD
Fulvestrant—Infestation—Orlistat—obesity	0.000405	0.00299	CcSEcCtD
Fulvestrant—Infestation NOS—Orlistat—obesity	0.000405	0.00299	CcSEcCtD
Fulvestrant—Depression—Orlistat—obesity	0.000403	0.00298	CcSEcCtD
Fulvestrant—Fatigue—Cimetidine—obesity	0.000403	0.00298	CcSEcCtD
Fulvestrant—Breast disorder—Bupropion—obesity	0.0004	0.00296	CcSEcCtD
Fulvestrant—Constipation—Cimetidine—obesity	0.0004	0.00295	CcSEcCtD
Fulvestrant—Estradiol—SHBG—obesity	0.000395	0.0846	CrCbGaD
Fulvestrant—Musculoskeletal pain—Topiramate—obesity	0.000393	0.00291	CcSEcCtD
Fulvestrant—Urinary tract infection—Orlistat—obesity	0.000393	0.00291	CcSEcCtD
Fulvestrant—Depression—Sibutramine—obesity	0.00039	0.00289	CcSEcCtD
Fulvestrant—Estradiol—SLC22A1—obesity	0.00039	0.0835	CrCbGaD
Fulvestrant—Urticaria—Diethylpropion—obesity	0.00039	0.00288	CcSEcCtD
Fulvestrant—ESR1—liver—obesity	0.00039	0.00482	CbGeAlD
Fulvestrant—Dizziness—Phenylpropanolamine—obesity	0.00039	0.00288	CcSEcCtD
Fulvestrant—Diarrhoea—Phentermine—obesity	0.000386	0.00286	CcSEcCtD
Fulvestrant—Influenza—Bupropion—obesity	0.000383	0.00283	CcSEcCtD
Fulvestrant—Hepatobiliary disease—Orlistat—obesity	0.000383	0.00283	CcSEcCtD
Fulvestrant—Urinary tract infection—Sibutramine—obesity	0.000381	0.00281	CcSEcCtD
Fulvestrant—Sweating—Sibutramine—obesity	0.000375	0.00277	CcSEcCtD
Fulvestrant—Vomiting—Phenylpropanolamine—obesity	0.000375	0.00277	CcSEcCtD
Fulvestrant—Dizziness—Phentermine—obesity	0.000373	0.00276	CcSEcCtD
Fulvestrant—Rash—Phenylpropanolamine—obesity	0.000372	0.00275	CcSEcCtD
Fulvestrant—Dermatitis—Phenylpropanolamine—obesity	0.000372	0.00275	CcSEcCtD
Fulvestrant—Body temperature increased—Cimetidine—obesity	0.000369	0.00273	CcSEcCtD
Fulvestrant—Haemoglobin—Orlistat—obesity	0.000365	0.0027	CcSEcCtD
Fulvestrant—Haemorrhage—Orlistat—obesity	0.000363	0.00268	CcSEcCtD
Fulvestrant—Hepatitis—Orlistat—obesity	0.000363	0.00268	CcSEcCtD
Fulvestrant—Pharyngitis—Orlistat—obesity	0.00036	0.00266	CcSEcCtD
Fulvestrant—Vomiting—Phentermine—obesity	0.000359	0.00265	CcSEcCtD
Fulvestrant—Oedema peripheral—Orlistat—obesity	0.000358	0.00264	CcSEcCtD
Fulvestrant—Rash—Phentermine—obesity	0.000356	0.00263	CcSEcCtD
Fulvestrant—Dermatitis—Phentermine—obesity	0.000356	0.00263	CcSEcCtD
Fulvestrant—Headache—Phentermine—obesity	0.000354	0.00261	CcSEcCtD
Fulvestrant—Haemoglobin—Sibutramine—obesity	0.000353	0.00261	CcSEcCtD
Fulvestrant—Haemorrhage—Sibutramine—obesity	0.000351	0.0026	CcSEcCtD
Fulvestrant—Nausea—Phenylpropanolamine—obesity	0.00035	0.00259	CcSEcCtD
Fulvestrant—Pharyngitis—Sibutramine—obesity	0.000349	0.00258	CcSEcCtD
Fulvestrant—Estradiol—AR—obesity	0.000347	0.0742	CrCbGaD
Fulvestrant—Oedema peripheral—Sibutramine—obesity	0.000346	0.00256	CcSEcCtD
Fulvestrant—Hypersensitivity—Cimetidine—obesity	0.000344	0.00255	CcSEcCtD
Fulvestrant—Infestation NOS—Bupropion—obesity	0.000341	0.00252	CcSEcCtD
Fulvestrant—Infestation—Bupropion—obesity	0.000341	0.00252	CcSEcCtD
Fulvestrant—Diarrhoea—Diethylpropion—obesity	0.000336	0.00248	CcSEcCtD
Fulvestrant—Nausea—Phentermine—obesity	0.000335	0.00248	CcSEcCtD
Fulvestrant—Asthenia—Cimetidine—obesity	0.000335	0.00248	CcSEcCtD
Fulvestrant—Urinary tract infection—Bupropion—obesity	0.000332	0.00245	CcSEcCtD
Fulvestrant—Immune system disorder—Orlistat—obesity	0.000328	0.00242	CcSEcCtD
Fulvestrant—Sweating—Bupropion—obesity	0.000327	0.00242	CcSEcCtD
Fulvestrant—Dizziness—Diethylpropion—obesity	0.000325	0.0024	CcSEcCtD
Fulvestrant—Diarrhoea—Cimetidine—obesity	0.00032	0.00236	CcSEcCtD
Fulvestrant—Angiopathy—Sibutramine—obesity	0.000319	0.00236	CcSEcCtD
Fulvestrant—Immune system disorder—Sibutramine—obesity	0.000317	0.00235	CcSEcCtD
Fulvestrant—Malnutrition—Orlistat—obesity	0.000316	0.00234	CcSEcCtD
Fulvestrant—Hepatic failure—Topiramate—obesity	0.000314	0.00232	CcSEcCtD
Fulvestrant—Vomiting—Diethylpropion—obesity	0.000312	0.00231	CcSEcCtD
Fulvestrant—Rash—Diethylpropion—obesity	0.00031	0.00229	CcSEcCtD
Fulvestrant—Dermatitis—Diethylpropion—obesity	0.000309	0.00229	CcSEcCtD
Fulvestrant—Dizziness—Cimetidine—obesity	0.000309	0.00228	CcSEcCtD
Fulvestrant—Haemoglobin—Bupropion—obesity	0.000308	0.00228	CcSEcCtD
Fulvestrant—Headache—Diethylpropion—obesity	0.000308	0.00227	CcSEcCtD
Fulvestrant—Haemorrhage—Bupropion—obesity	0.000306	0.00226	CcSEcCtD
Fulvestrant—Hepatitis—Bupropion—obesity	0.000306	0.00226	CcSEcCtD
Fulvestrant—Malnutrition—Sibutramine—obesity	0.000306	0.00226	CcSEcCtD
Fulvestrant—Back pain—Orlistat—obesity	0.000306	0.00226	CcSEcCtD
Fulvestrant—Pharyngitis—Bupropion—obesity	0.000304	0.00225	CcSEcCtD
Fulvestrant—Oedema peripheral—Bupropion—obesity	0.000302	0.00223	CcSEcCtD
Fulvestrant—Hot flush—Topiramate—obesity	0.000302	0.00223	CcSEcCtD
Fulvestrant—Connective tissue disorder—Bupropion—obesity	0.000301	0.00223	CcSEcCtD
Fulvestrant—Menopausal symptoms—Topiramate—obesity	0.000299	0.00221	CcSEcCtD
Fulvestrant—Vomiting—Cimetidine—obesity	0.000297	0.0022	CcSEcCtD
Fulvestrant—Back pain—Sibutramine—obesity	0.000296	0.00219	CcSEcCtD
Fulvestrant—Rash—Cimetidine—obesity	0.000295	0.00218	CcSEcCtD
Fulvestrant—Dermatitis—Cimetidine—obesity	0.000294	0.00218	CcSEcCtD
Fulvestrant—Headache—Cimetidine—obesity	0.000293	0.00216	CcSEcCtD
Fulvestrant—CYP3A4—digestive system—obesity	0.000292	0.00361	CbGeAlD
Fulvestrant—Nausea—Diethylpropion—obesity	0.000292	0.00216	CcSEcCtD
Fulvestrant—Angioedema—Orlistat—obesity	0.000289	0.00214	CcSEcCtD
Fulvestrant—Vertigo—Orlistat—obesity	0.000284	0.0021	CcSEcCtD
Fulvestrant—Anaemia—Sibutramine—obesity	0.000283	0.00209	CcSEcCtD
Fulvestrant—Pain in extremity—Topiramate—obesity	0.000282	0.00209	CcSEcCtD
Fulvestrant—Angioedema—Sibutramine—obesity	0.00028	0.00207	CcSEcCtD
Fulvestrant—Angiopathy—Bupropion—obesity	0.000278	0.00205	CcSEcCtD
Fulvestrant—Nausea—Cimetidine—obesity	0.000278	0.00205	CcSEcCtD
Fulvestrant—Immune system disorder—Bupropion—obesity	0.000277	0.00205	CcSEcCtD
Fulvestrant—Cough—Orlistat—obesity	0.000276	0.00204	CcSEcCtD
Fulvestrant—Vertigo—Sibutramine—obesity	0.000275	0.00203	CcSEcCtD
Fulvestrant—Leukopenia—Sibutramine—obesity	0.000274	0.00202	CcSEcCtD
Fulvestrant—Chest pain—Orlistat—obesity	0.000269	0.00199	CcSEcCtD
Fulvestrant—Myalgia—Orlistat—obesity	0.000269	0.00199	CcSEcCtD
Fulvestrant—Anxiety—Orlistat—obesity	0.000268	0.00198	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000267	0.00198	CcSEcCtD
Fulvestrant—Estradiol—ESR1—obesity	0.000267	0.0571	CrCbGaD
Fulvestrant—Cough—Sibutramine—obesity	0.000267	0.00197	CcSEcCtD
Fulvestrant—Malnutrition—Bupropion—obesity	0.000267	0.00197	CcSEcCtD
Fulvestrant—Myalgia—Sibutramine—obesity	0.00026	0.00193	CcSEcCtD
Fulvestrant—Arthralgia—Sibutramine—obesity	0.00026	0.00193	CcSEcCtD
Fulvestrant—Chest pain—Sibutramine—obesity	0.00026	0.00193	CcSEcCtD
Fulvestrant—Anxiety—Sibutramine—obesity	0.00026	0.00192	CcSEcCtD
Fulvestrant—Back pain—Bupropion—obesity	0.000258	0.00191	CcSEcCtD
Fulvestrant—Infection—Orlistat—obesity	0.000256	0.00189	CcSEcCtD
Fulvestrant—Breast disorder—Topiramate—obesity	0.000255	0.00188	CcSEcCtD
Fulvestrant—Nervous system disorder—Orlistat—obesity	0.000253	0.00187	CcSEcCtD
Fulvestrant—Skin disorder—Orlistat—obesity	0.000251	0.00185	CcSEcCtD
Fulvestrant—Hyperhidrosis—Orlistat—obesity	0.000249	0.00184	CcSEcCtD
Fulvestrant—Infection—Sibutramine—obesity	0.000248	0.00183	CcSEcCtD
Fulvestrant—Anaemia—Bupropion—obesity	0.000247	0.00182	CcSEcCtD
Fulvestrant—Angioedema—Bupropion—obesity	0.000244	0.0018	CcSEcCtD
Fulvestrant—Skin disorder—Sibutramine—obesity	0.000243	0.00179	CcSEcCtD
Fulvestrant—CYP3A4—endocrine gland—obesity	0.000241	0.00298	CbGeAlD
Fulvestrant—Hyperhidrosis—Sibutramine—obesity	0.000241	0.00178	CcSEcCtD
Fulvestrant—Vertigo—Bupropion—obesity	0.00024	0.00177	CcSEcCtD
Fulvestrant—Leukopenia—Bupropion—obesity	0.000239	0.00176	CcSEcCtD
Fulvestrant—Anorexia—Sibutramine—obesity	0.000238	0.00176	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Orlistat—obesity	0.000235	0.00174	CcSEcCtD
Fulvestrant—Insomnia—Orlistat—obesity	0.000233	0.00172	CcSEcCtD
Fulvestrant—Cough—Bupropion—obesity	0.000233	0.00172	CcSEcCtD
Fulvestrant—Paraesthesia—Orlistat—obesity	0.000232	0.00171	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Sibutramine—obesity	0.000227	0.00168	CcSEcCtD
Fulvestrant—Dyspepsia—Orlistat—obesity	0.000227	0.00168	CcSEcCtD
Fulvestrant—Chest pain—Bupropion—obesity	0.000227	0.00168	CcSEcCtD
Fulvestrant—Myalgia—Bupropion—obesity	0.000227	0.00168	CcSEcCtD
Fulvestrant—Arthralgia—Bupropion—obesity	0.000227	0.00168	CcSEcCtD
Fulvestrant—Anxiety—Bupropion—obesity	0.000226	0.00167	CcSEcCtD
Fulvestrant—Insomnia—Sibutramine—obesity	0.000226	0.00167	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000226	0.00167	CcSEcCtD
Fulvestrant—Decreased appetite—Orlistat—obesity	0.000224	0.00166	CcSEcCtD
Fulvestrant—Paraesthesia—Sibutramine—obesity	0.000224	0.00166	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Orlistat—obesity	0.000223	0.00165	CcSEcCtD
Fulvestrant—Dyspnoea—Sibutramine—obesity	0.000223	0.00165	CcSEcCtD
Fulvestrant—Fatigue—Orlistat—obesity	0.000222	0.00164	CcSEcCtD
Fulvestrant—Pain—Orlistat—obesity	0.000221	0.00163	CcSEcCtD
Fulvestrant—Dyspepsia—Sibutramine—obesity	0.00022	0.00162	CcSEcCtD
Fulvestrant—CYP3A4—liver—obesity	0.000218	0.00269	CbGeAlD
Fulvestrant—Infestation NOS—Topiramate—obesity	0.000217	0.00161	CcSEcCtD
Fulvestrant—Infestation—Topiramate—obesity	0.000217	0.00161	CcSEcCtD
Fulvestrant—Decreased appetite—Sibutramine—obesity	0.000217	0.0016	CcSEcCtD
Fulvestrant—Depression—Topiramate—obesity	0.000217	0.0016	CcSEcCtD
Fulvestrant—Infection—Bupropion—obesity	0.000216	0.0016	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Sibutramine—obesity	0.000216	0.00159	CcSEcCtD
Fulvestrant—Pain—Sibutramine—obesity	0.000214	0.00158	CcSEcCtD
Fulvestrant—Constipation—Sibutramine—obesity	0.000214	0.00158	CcSEcCtD
Fulvestrant—Nervous system disorder—Bupropion—obesity	0.000213	0.00158	CcSEcCtD
Fulvestrant—Skin disorder—Bupropion—obesity	0.000211	0.00156	CcSEcCtD
Fulvestrant—Urinary tract infection—Topiramate—obesity	0.000211	0.00156	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Orlistat—obesity	0.000211	0.00156	CcSEcCtD
Fulvestrant—Hyperhidrosis—Bupropion—obesity	0.00021	0.00156	CcSEcCtD
Fulvestrant—Anorexia—Bupropion—obesity	0.000207	0.00153	CcSEcCtD
Fulvestrant—Urticaria—Orlistat—obesity	0.000205	0.00152	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Sibutramine—obesity	0.000204	0.00151	CcSEcCtD
Fulvestrant—Abdominal pain—Orlistat—obesity	0.000204	0.00151	CcSEcCtD
Fulvestrant—Body temperature increased—Orlistat—obesity	0.000204	0.00151	CcSEcCtD
Fulvestrant—Urticaria—Sibutramine—obesity	0.000198	0.00147	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Bupropion—obesity	0.000198	0.00147	CcSEcCtD
Fulvestrant—Abdominal pain—Sibutramine—obesity	0.000197	0.00146	CcSEcCtD
Fulvestrant—Body temperature increased—Sibutramine—obesity	0.000197	0.00146	CcSEcCtD
Fulvestrant—Insomnia—Bupropion—obesity	0.000197	0.00146	CcSEcCtD
Fulvestrant—Haemoglobin—Topiramate—obesity	0.000196	0.00145	CcSEcCtD
Fulvestrant—Paraesthesia—Bupropion—obesity	0.000195	0.00144	CcSEcCtD
Fulvestrant—Haemorrhage—Topiramate—obesity	0.000195	0.00144	CcSEcCtD
Fulvestrant—Hepatitis—Topiramate—obesity	0.000195	0.00144	CcSEcCtD
Fulvestrant—Dyspnoea—Bupropion—obesity	0.000194	0.00143	CcSEcCtD
Fulvestrant—Pharyngitis—Topiramate—obesity	0.000194	0.00143	CcSEcCtD
Fulvestrant—Oedema peripheral—Topiramate—obesity	0.000192	0.00142	CcSEcCtD
Fulvestrant—Connective tissue disorder—Topiramate—obesity	0.000192	0.00142	CcSEcCtD
Fulvestrant—Dyspepsia—Bupropion—obesity	0.000192	0.00142	CcSEcCtD
Fulvestrant—Hypersensitivity—Orlistat—obesity	0.00019	0.00141	CcSEcCtD
Fulvestrant—Decreased appetite—Bupropion—obesity	0.000189	0.0014	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Bupropion—obesity	0.000188	0.00139	CcSEcCtD
Fulvestrant—Fatigue—Bupropion—obesity	0.000188	0.00139	CcSEcCtD
Fulvestrant—Constipation—Bupropion—obesity	0.000186	0.00138	CcSEcCtD
Fulvestrant—Pain—Bupropion—obesity	0.000186	0.00138	CcSEcCtD
Fulvestrant—Asthenia—Orlistat—obesity	0.000185	0.00137	CcSEcCtD
Fulvestrant—Hypersensitivity—Sibutramine—obesity	0.000184	0.00136	CcSEcCtD
Fulvestrant—Pruritus—Orlistat—obesity	0.000183	0.00135	CcSEcCtD
Fulvestrant—Asthenia—Sibutramine—obesity	0.000179	0.00132	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Bupropion—obesity	0.000178	0.00132	CcSEcCtD
Fulvestrant—Angiopathy—Topiramate—obesity	0.000177	0.00131	CcSEcCtD
Fulvestrant—Pruritus—Sibutramine—obesity	0.000177	0.00131	CcSEcCtD
Fulvestrant—Diarrhoea—Orlistat—obesity	0.000177	0.0013	CcSEcCtD
Fulvestrant—Immune system disorder—Topiramate—obesity	0.000176	0.0013	CcSEcCtD
Fulvestrant—Urticaria—Bupropion—obesity	0.000173	0.00128	CcSEcCtD
Fulvestrant—Abdominal pain—Bupropion—obesity	0.000172	0.00127	CcSEcCtD
Fulvestrant—Body temperature increased—Bupropion—obesity	0.000172	0.00127	CcSEcCtD
Fulvestrant—Diarrhoea—Sibutramine—obesity	0.000171	0.00126	CcSEcCtD
Fulvestrant—Dizziness—Orlistat—obesity	0.000171	0.00126	CcSEcCtD
Fulvestrant—Malnutrition—Topiramate—obesity	0.00017	0.00126	CcSEcCtD
Fulvestrant—Dizziness—Sibutramine—obesity	0.000165	0.00122	CcSEcCtD
Fulvestrant—Back pain—Topiramate—obesity	0.000164	0.00122	CcSEcCtD
Fulvestrant—Vomiting—Orlistat—obesity	0.000164	0.00121	CcSEcCtD
Fulvestrant—Rash—Orlistat—obesity	0.000163	0.0012	CcSEcCtD
Fulvestrant—Dermatitis—Orlistat—obesity	0.000163	0.0012	CcSEcCtD
Fulvestrant—Headache—Orlistat—obesity	0.000162	0.00119	CcSEcCtD
Fulvestrant—Hypersensitivity—Bupropion—obesity	0.00016	0.00119	CcSEcCtD
Fulvestrant—Vomiting—Sibutramine—obesity	0.000159	0.00117	CcSEcCtD
Fulvestrant—Rash—Sibutramine—obesity	0.000157	0.00116	CcSEcCtD
Fulvestrant—Dermatitis—Sibutramine—obesity	0.000157	0.00116	CcSEcCtD
Fulvestrant—Anaemia—Topiramate—obesity	0.000157	0.00116	CcSEcCtD
Fulvestrant—Headache—Sibutramine—obesity	0.000156	0.00116	CcSEcCtD
Fulvestrant—Asthenia—Bupropion—obesity	0.000156	0.00115	CcSEcCtD
Fulvestrant—Pruritus—Bupropion—obesity	0.000154	0.00114	CcSEcCtD
Fulvestrant—Nausea—Orlistat—obesity	0.000153	0.00113	CcSEcCtD
Fulvestrant—Vertigo—Topiramate—obesity	0.000153	0.00113	CcSEcCtD
Fulvestrant—Leukopenia—Topiramate—obesity	0.000152	0.00112	CcSEcCtD
Fulvestrant—Diarrhoea—Bupropion—obesity	0.000149	0.0011	CcSEcCtD
Fulvestrant—Nausea—Sibutramine—obesity	0.000148	0.0011	CcSEcCtD
Fulvestrant—Cough—Topiramate—obesity	0.000148	0.0011	CcSEcCtD
Fulvestrant—Myalgia—Topiramate—obesity	0.000145	0.00107	CcSEcCtD
Fulvestrant—Chest pain—Topiramate—obesity	0.000145	0.00107	CcSEcCtD
Fulvestrant—Arthralgia—Topiramate—obesity	0.000145	0.00107	CcSEcCtD
Fulvestrant—Anxiety—Topiramate—obesity	0.000144	0.00107	CcSEcCtD
Fulvestrant—Dizziness—Bupropion—obesity	0.000144	0.00106	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000144	0.00106	CcSEcCtD
Fulvestrant—Vomiting—Bupropion—obesity	0.000138	0.00102	CcSEcCtD
Fulvestrant—Infection—Topiramate—obesity	0.000138	0.00102	CcSEcCtD
Fulvestrant—Rash—Bupropion—obesity	0.000137	0.00101	CcSEcCtD
Fulvestrant—Dermatitis—Bupropion—obesity	0.000137	0.00101	CcSEcCtD
Fulvestrant—Headache—Bupropion—obesity	0.000136	0.00101	CcSEcCtD
Fulvestrant—Nervous system disorder—Topiramate—obesity	0.000136	0.00101	CcSEcCtD
Fulvestrant—Skin disorder—Topiramate—obesity	0.000135	0.000996	CcSEcCtD
Fulvestrant—Hyperhidrosis—Topiramate—obesity	0.000134	0.000991	CcSEcCtD
Fulvestrant—Anorexia—Topiramate—obesity	0.000132	0.000977	CcSEcCtD
Fulvestrant—Nausea—Bupropion—obesity	0.000129	0.000956	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Topiramate—obesity	0.000126	0.000934	CcSEcCtD
Fulvestrant—Insomnia—Topiramate—obesity	0.000125	0.000927	CcSEcCtD
Fulvestrant—Paraesthesia—Topiramate—obesity	0.000125	0.000921	CcSEcCtD
Fulvestrant—Dyspnoea—Topiramate—obesity	0.000124	0.000914	CcSEcCtD
Fulvestrant—Dyspepsia—Topiramate—obesity	0.000122	0.000902	CcSEcCtD
Fulvestrant—Decreased appetite—Topiramate—obesity	0.000121	0.000891	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Topiramate—obesity	0.00012	0.000885	CcSEcCtD
Fulvestrant—Fatigue—Topiramate—obesity	0.00012	0.000884	CcSEcCtD
Fulvestrant—Estradiol—ALB—obesity	0.000119	0.0254	CrCbGaD
Fulvestrant—Constipation—Topiramate—obesity	0.000119	0.000877	CcSEcCtD
Fulvestrant—Pain—Topiramate—obesity	0.000119	0.000877	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Topiramate—obesity	0.000113	0.000838	CcSEcCtD
Fulvestrant—Urticaria—Topiramate—obesity	0.00011	0.000814	CcSEcCtD
Fulvestrant—Body temperature increased—Topiramate—obesity	0.00011	0.00081	CcSEcCtD
Fulvestrant—Abdominal pain—Topiramate—obesity	0.00011	0.00081	CcSEcCtD
Fulvestrant—Hypersensitivity—Topiramate—obesity	0.000102	0.000755	CcSEcCtD
Fulvestrant—Asthenia—Topiramate—obesity	9.95e-05	0.000736	CcSEcCtD
Fulvestrant—Pruritus—Topiramate—obesity	9.81e-05	0.000725	CcSEcCtD
Fulvestrant—Diarrhoea—Topiramate—obesity	9.49e-05	0.000701	CcSEcCtD
Fulvestrant—Dizziness—Topiramate—obesity	9.17e-05	0.000678	CcSEcCtD
Fulvestrant—Vomiting—Topiramate—obesity	8.82e-05	0.000652	CcSEcCtD
Fulvestrant—Rash—Topiramate—obesity	8.74e-05	0.000646	CcSEcCtD
Fulvestrant—Dermatitis—Topiramate—obesity	8.74e-05	0.000646	CcSEcCtD
Fulvestrant—Headache—Topiramate—obesity	8.69e-05	0.000642	CcSEcCtD
Fulvestrant—Nausea—Topiramate—obesity	8.24e-05	0.000609	CcSEcCtD
Fulvestrant—NR1H4—Metabolism—APOE—obesity	1.07e-05	6.95e-05	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—obesity	1.07e-05	6.92e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CAV1—obesity	1.06e-05	6.89e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—APOA1—obesity	1.06e-05	6.87e-05	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—AKT1—obesity	1.05e-05	6.82e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—AKT1—obesity	1.05e-05	6.78e-05	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—PPARG—obesity	1.05e-05	6.78e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GLRX—obesity	1.02e-05	6.61e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.02e-05	6.58e-05	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PIK3CB—obesity	1.02e-05	6.58e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PARP1—obesity	1.01e-05	6.52e-05	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PTGS2—obesity	1.01e-05	6.52e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ADRB3—obesity	1.01e-05	6.5e-05	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—SERPINE1—obesity	9.89e-06	6.4e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GAL—obesity	9.82e-06	6.35e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—C5AR1—obesity	9.71e-06	6.28e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PIK3CG—obesity	9.7e-06	6.27e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—ESR2—obesity	9.55e-06	6.18e-05	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—SERPINE1—obesity	9.44e-06	6.11e-05	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—MYC—obesity	9.39e-06	6.07e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PPARG—obesity	9.36e-06	6.05e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—POMC—obesity	9.23e-06	5.97e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—INS—obesity	9.18e-06	5.94e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ETFDH—obesity	9.12e-06	5.9e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—OTC—obesity	9.12e-06	5.9e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPM1L—obesity	9.12e-06	5.9e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—INSIG2—obesity	9.12e-06	5.9e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCK—obesity	8.88e-06	5.74e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PRKG1—obesity	8.88e-06	5.74e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—NCOA1—obesity	8.8e-06	5.69e-05	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—obesity	8.74e-06	5.65e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RBP4—obesity	8.65e-06	5.6e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GLP1R—obesity	8.65e-06	5.6e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PIK3CD—obesity	8.53e-06	5.51e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCKAR—obesity	8.51e-06	5.51e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HRH3—obesity	8.51e-06	5.51e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—AR—obesity	8.44e-06	5.46e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ALB—obesity	8.42e-06	5.44e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—INPP5E—obesity	8.34e-06	5.39e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GPT—obesity	8.34e-06	5.39e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—UQCRC2—obesity	8.34e-06	5.39e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PRKAR2B—obesity	8.2e-06	5.3e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—NOS3—obesity	8.05e-06	5.21e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PIK3R1—obesity	8.05e-06	5.21e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NCF2—obesity	7.92e-06	5.12e-05	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PIK3CA—obesity	7.75e-06	5.01e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ME1—obesity	7.75e-06	5.01e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SUCLG2—obesity	7.75e-06	5.01e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALDH6A1—obesity	7.75e-06	5.01e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—POMC—obesity	7.73e-06	5e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NPY—obesity	7.71e-06	4.99e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—SIRT1—obesity	7.69e-06	4.98e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IAPP—obesity	7.67e-06	4.96e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APOC3—obesity	7.67e-06	4.96e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CRH—obesity	7.44e-06	4.81e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HTR1B—obesity	7.44e-06	4.81e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PIK3CB—obesity	7.43e-06	4.81e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PTGS2—obesity	7.36e-06	4.76e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SDC1—obesity	7.36e-06	4.76e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—COX7C—obesity	7.29e-06	4.71e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PNPLA3—obesity	7.29e-06	4.71e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—UCP1—obesity	7.29e-06	4.71e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AKR1C3—obesity	7.24e-06	4.68e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NPS—obesity	7.05e-06	4.56e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—DRD1—obesity	6.92e-06	4.47e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HTR2C—obesity	6.92e-06	4.47e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SUCLA2—obesity	6.91e-06	4.47e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CS—obesity	6.91e-06	4.47e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CPS1—obesity	6.91e-06	4.47e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—DGAT2—obesity	6.91e-06	4.47e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—MYC—obesity	6.86e-06	4.44e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—NR3C1—obesity	6.82e-06	4.41e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NTRK2—obesity	6.73e-06	4.35e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ADRB1—obesity	6.7e-06	4.33e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PRKCD—obesity	6.67e-06	4.31e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—MUT—obesity	6.59e-06	4.26e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LIPE—obesity	6.59e-06	4.26e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GHRL—obesity	6.56e-06	4.24e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PARP1—obesity	6.56e-06	4.24e-05	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—AKT1—obesity	6.51e-06	4.21e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—DRD4—obesity	6.5e-06	4.21e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PPARA—obesity	6.39e-06	4.14e-05	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—AKT1—obesity	6.33e-06	4.1e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYB5A—obesity	6.32e-06	4.09e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—DGAT1—obesity	6.32e-06	4.09e-05	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—MYC—obesity	6.26e-06	4.05e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CNR1—obesity	6.21e-06	4.02e-05	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PIK3CA—obesity	6.2e-06	4.01e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TCF7L2—obesity	6.1e-06	3.95e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ACLY—obesity	6.08e-06	3.93e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—DRD2—obesity	6.06e-06	3.92e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PTPN1—obesity	6e-06	3.88e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GCG—obesity	6e-06	3.88e-05	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—MYC—obesity	5.98e-06	3.86e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ENPP1—obesity	5.87e-06	3.8e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALOX12—obesity	5.87e-06	3.8e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PRL—obesity	5.72e-06	3.7e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HMGCS1—obesity	5.69e-06	3.68e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—STK11—obesity	5.64e-06	3.65e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PLG—obesity	5.58e-06	3.61e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PNPLA2—obesity	5.52e-06	3.57e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ACADM—obesity	5.52e-06	3.57e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PLIN1—obesity	5.52e-06	3.57e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PFKFB3—obesity	5.52e-06	3.57e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SAT1—obesity	5.52e-06	3.57e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ANGPTL4—obesity	5.52e-06	3.57e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FOXO3—obesity	5.44e-06	3.52e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ADRB2—obesity	5.43e-06	3.51e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYTB—obesity	5.37e-06	3.47e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ACACB—obesity	5.37e-06	3.47e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—OXCT1—obesity	5.37e-06	3.47e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SOCS1—obesity	5.35e-06	3.46e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PPARG—obesity	5.29e-06	3.42e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SOCS3—obesity	5.28e-06	3.42e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SRD5A1—obesity	5.24e-06	3.39e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PNLIP—obesity	5.24e-06	3.39e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GNB3—obesity	5.17e-06	3.34e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SDC3—obesity	5.11e-06	3.3e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IGF2—obesity	5.08e-06	3.28e-05	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—AKT1—obesity	5.06e-06	3.27e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GNAS—obesity	5.03e-06	3.26e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP26B1—obesity	4.99e-06	3.23e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—STS—obesity	4.99e-06	3.23e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HK2—obesity	4.99e-06	3.23e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APOB—obesity	4.93e-06	3.19e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPARD—obesity	4.89e-06	3.16e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCL5—obesity	4.81e-06	3.11e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SLC27A1—obesity	4.79e-06	3.1e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—SERPINE1—obesity	4.76e-06	3.08e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—AKT1—obesity	4.76e-06	3.08e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—LPL—obesity	4.71e-06	3.04e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GLUL—obesity	4.7e-06	3.04e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—FABP4—obesity	4.7e-06	3.04e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FOXO1—obesity	4.67e-06	3.02e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RPS6KB1—obesity	4.67e-06	3.02e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PIK3CA—obesity	4.53e-06	2.93e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ECHS1—obesity	4.45e-06	2.88e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HSD11B1—obesity	4.45e-06	2.88e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—UCP3—obesity	4.45e-06	2.88e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—UCP2—obesity	4.45e-06	2.88e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ADH1B—obesity	4.38e-06	2.83e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PRKCD—obesity	4.34e-06	2.8e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ACSL1—obesity	4.31e-06	2.79e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPARGC1B—obesity	4.31e-06	2.79e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GPAM—obesity	4.31e-06	2.79e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HTR2A—obesity	4.24e-06	2.74e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—C3—obesity	4.24e-06	2.74e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PCK1—obesity	4.19e-06	2.71e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—FADS1—obesity	4.19e-06	2.71e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HADH—obesity	4.19e-06	2.71e-05	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—AKT1—obesity	4.14e-06	2.68e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ACP5—obesity	4.07e-06	2.63e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IRS2—obesity	4.03e-06	2.61e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AGT—obesity	4.03e-06	2.6e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—G6PD—obesity	3.97e-06	2.57e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APOE—obesity	3.95e-06	2.55e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—LEP—obesity	3.95e-06	2.55e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HK1—obesity	3.92e-06	2.53e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SREBF2—obesity	3.92e-06	2.53e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CAV1—obesity	3.91e-06	2.53e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APOA1—obesity	3.9e-06	2.52e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LPA—obesity	3.79e-06	2.45e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PRKCB—obesity	3.72e-06	2.41e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—F2—obesity	3.72e-06	2.41e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LPIN1—obesity	3.7e-06	2.4e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—AKT1—obesity	3.7e-06	2.39e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—BAD—obesity	3.68e-06	2.38e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOA5—obesity	3.63e-06	2.35e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PIK3CG—obesity	3.56e-06	2.3e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IRS1—obesity	3.52e-06	2.28e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SLC22A1—obesity	3.46e-06	2.24e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CLOCK—obesity	3.46e-06	2.24e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—POMC—obesity	3.39e-06	2.19e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SULT2A1—obesity	3.37e-06	2.18e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GLP1R—obesity	3.37e-06	2.18e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—INS—obesity	3.37e-06	2.18e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—DPYD—obesity	3.32e-06	2.15e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCL2—obesity	3.32e-06	2.14e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IGF1—obesity	3.26e-06	2.11e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AKT2—obesity	3.26e-06	2.11e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PRKAR2B—obesity	3.19e-06	2.07e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—DCN—obesity	3.17e-06	2.05e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PIK3CD—obesity	3.13e-06	2.02e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SERPINE1—obesity	3.1e-06	2e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CPT1A—obesity	3.09e-06	2e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NAMPT—obesity	3.03e-06	1.96e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—MYC—obesity	3.01e-06	1.95e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TYK2—obesity	3.01e-06	1.95e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LIPC—obesity	3.01e-06	1.94e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GCK—obesity	3.01e-06	1.94e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOC3—obesity	2.99e-06	1.93e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RHOA—obesity	2.99e-06	1.93e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PIK3R1—obesity	2.96e-06	1.91e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NOS3—obesity	2.96e-06	1.91e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CETP—obesity	2.9e-06	1.88e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SDC1—obesity	2.87e-06	1.86e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AKR1C3—obesity	2.82e-06	1.83e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SCARB1—obesity	2.78e-06	1.8e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PIK3CB—obesity	2.73e-06	1.76e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MTOR—obesity	2.73e-06	1.76e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SREBF1—obesity	2.7e-06	1.74e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GOT2—obesity	2.62e-06	1.7e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—FASN—obesity	2.57e-06	1.66e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—BCHE—obesity	2.56e-06	1.65e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP2E1—obesity	2.47e-06	1.6e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NQO1—obesity	2.44e-06	1.58e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MMP9—obesity	2.37e-06	1.53e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GCG—obesity	2.34e-06	1.51e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SLC2A4—obesity	2.34e-06	1.51e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYCS—obesity	2.31e-06	1.49e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MAPK8—obesity	2.31e-06	1.49e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GOT1—obesity	2.26e-06	1.46e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GGT1—obesity	2.26e-06	1.46e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NCOA1—obesity	2.23e-06	1.44e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP19A1—obesity	2.2e-06	1.42e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—STK11—obesity	2.2e-06	1.42e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—STAT3—obesity	2.11e-06	1.36e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—AKT1—obesity	2.09e-06	1.35e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—COMT—obesity	2.04e-06	1.32e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GNB3—obesity	2.02e-06	1.3e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPARGC1A—obesity	2.02e-06	1.3e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HMOX1—obesity	2.01e-06	1.3e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GNAS—obesity	1.96e-06	1.27e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MYC—obesity	1.96e-06	1.27e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TGFB1—obesity	1.95e-06	1.26e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOB—obesity	1.92e-06	1.24e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LPL—obesity	1.84e-06	1.19e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GPX1—obesity	1.79e-06	1.16e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CD36—obesity	1.74e-06	1.13e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PIK3CA—obesity	1.66e-06	1.08e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—MTHFR—obesity	1.65e-06	1.07e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPARA—obesity	1.62e-06	1.05e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AGT—obesity	1.57e-06	1.02e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOE—obesity	1.54e-06	9.95e-06	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CAV1—obesity	1.52e-06	9.86e-06	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOA1—obesity	1.52e-06	9.83e-06	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL6—obesity	1.47e-06	9.53e-06	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PIK3CG—obesity	1.39e-06	8.98e-06	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AKT1—obesity	1.36e-06	8.79e-06	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPARG—obesity	1.34e-06	8.66e-06	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—POMC—obesity	1.32e-06	8.55e-06	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—INS—obesity	1.31e-06	8.5e-06	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PIK3CD—obesity	1.22e-06	7.89e-06	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALB—obesity	1.2e-06	7.79e-06	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PIK3R1—obesity	1.15e-06	7.45e-06	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NOS3—obesity	1.15e-06	7.45e-06	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PIK3CB—obesity	1.06e-06	6.88e-06	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PTGS2—obesity	1.05e-06	6.82e-06	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PIK3CA—obesity	6.48e-07	4.19e-06	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AKT1—obesity	5.3e-07	3.43e-06	CbGpPWpGaD
